First FDA Approval for HDV: A Milestone in Hepatology
The FDA approved Hepcludex (bulevirtide) as the first treatment for chronic HDV. Learn what this milestone means for patients with hepatitis delta.
The FDA approved Hepcludex (bulevirtide) as the first treatment for chronic HDV. Learn what this milestone means for patients with hepatitis delta.